Fevertree expects to beat consensus on second half "momentum"

Thu, 29th Jan 2026 10:59

(Alliance News) - Fevertree Drinks PLC on Thursday said it expects annual earnings "marginally ahead" of market expectations, hailing "excellent progress in 2025".

The maker of premium drink mixers expects an adjusted revenue and adjusted earnings before interest, tax, depreciation and amortisation beat amid "momentum in the second half".

Fevertee explained the adjusted revenue figure brings "US revenue in line with invoiced sales to customers".

London-based expects 2025 adjusted revenue to increase 1.8% to GBP375.3 million from GBP368.5 million. At constant currency, it rose 3%. Fevertree puts consensus at GBP372.4 million. Adjusted Ebitda consensus is GBP44.4 million, which would represent a decline from GBP50.7 million reported for 2024.

The company said it is "comfortable with current 2026 market expectations". Revenue consensus for 2026 is GBP409.4 million. For adjusted Ebitda it is GBP49.9 million.

"We made excellent progress in 2025. Our partnership with Molson Coors in the US is progressing well, and the momentum behind the brand is especially encouraging, giving us confidence in the growing opportunity in our largest market as execution moves beyond the transition phase," Chief Executive Officer Tim Warrillow said.

"Across all our markets, we are continuing to build momentum as we broaden Fever-Tree beyond tonic, positioning the brand as not only the premium mixer but also premium soft drink of choice. We are uniquely positioned to unlock the growth opportunities afforded by the consumer trends towards moderation, premiumisation and longer, lighter serves. With exciting marketing campaigns and a strong innovation pipeline, delivered by our passionate team, I am confident we will drive strong growth in 2026 and beyond."

Fevertree announces annual results on March 24.

Shares in the company rose 3.7% to 927.30 pence each in London on Thursday morning. Its GBP1.07 billion market capitalisation makes it one of the largest constituents on London's AIM market.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Fevertree